Last10K.com

Sanuwave Health, Inc. (SNWV) SEC Filing S-1 IPO report for the period ending Monday, October 5, 2020

SEC Filings

SNWV Registration of Securities

    S-1 Registration of Securities June 2023
    S-1 Registration of Securities October 2022
  • S-1 Registration of Securities October 2020

Sanuwave Health, Inc.

CIK: 1587987 Ticker: SNWV

View differences made from one to another to evaluate Sanuwave Health, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this S-1 Registration of Securities to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sanuwave Health, Inc..

Continue

Assess how Sanuwave Health, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sanuwave Health, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this S-1 Registration of Securities

Document And Entity Information
Condensed Consolidated Balance Sheets (Fy)
Condensed Consolidated Balance Sheets (Fy) (Parenthetical)
Condensed Consolidated Balance Sheets (Q2)
Condensed Consolidated Balance Sheets (Q2) (Parenthetical)
Condensed Consolidated Statements Of Cash Flows (Q2) (Unaudited)
Condensed Consolidated Statements Of Cash Flows (Unaudited) (Fy)
Condensed Consolidated Statements Of Comprehensive Loss (Q2) (Unaudited)
Condensed Consolidated Statements Of Comprehensive Loss (Unaudited) (Fy)
Consolidated Statements Of Stockholders' Deficit (Fy)
Consolidated Statements Of Stockholders' Deficit (Q2)
Accrued Expenses (Fy)
Accrued Expenses (Fy) (Details)
Accrued Expenses (Fy) (Tables)
Accrued Expenses (Narrative) (Fy) (Details)
Advances From Related Parties (Fy)
Advances From Related Parties (Narrative) (Fy) (Details)
Commitments And Contingencies (Fy)
Commitments And Contingencies (Fy) (1) (Details)
Commitments And Contingencies (Fy) (2) (Details)
Commitments And Contingencies (Fy) (Details)
Commitments And Contingencies (Fy) (Tables)
Commitments And Contingencies (Narrative) (Fy) (Details)
Contract Liabilities (Fy)
Contract Liabilities (Fy) (Details)
Contract Liabilities (Fy) (Tables)
Contract Liabilities (Narrative) (Fy) (Details)
Convertible Promissory Notes (Fy)
Convertible Promissory Notes (Fy) (1) (Details)
Convertible Promissory Notes (Fy) (Details)
Convertible Promissory Notes (Fy) (Tables)
Convertible Promissory Notes (Narrative) (Fy) (Details)
Description Of The Business And Going Concern And Management's Plans (Fy)
Description Of The Business And Going Concern And Management's Plans (Narrative) (Fy) (Details)
Equity Transactions (Fy)
Equity Transactions (Narrative) (Fy) (Details)
Income Taxes (Fy)
Income Taxes (Fy) (1) (Details)
Income Taxes (Fy) (2) (Details)
Income Taxes (Fy) (Details)
Income Taxes (Fy) (Tables)
Inventory (Fy)
Inventory (Fy) (Details)
Inventory (Fy) (Tables)
Joint Ventures (Fy)
Joint Ventures (Fy) (Details)
Line Of Credit, Related Parties (Fy)
Line Of Credit, Related Parties (Narrative) (Fy) (Details)
Note 1 - Nature Of The Business (Q2)
Note 10 - Preferred Stock (Narrative) (Q2) (Details)
Note 10 - Preferred Stock (Q2)
Note 11 - Equity Transactions (Narrative) (Q2) (Details)
Note 11 - Equity Transactions (Q2)
Note 12 - Warrants (Q2)
Note 12 - Warrants (Q2) (1) (Details)
Note 12 - Warrants (Q2) (2) (Details)
Note 12 - Warrants (Q2) (Details)
Note 12 - Warrants (Q2) (Tables)
Note 13 - Commitments And Contingencies (Narrative) (Q2) (Details)
Note 13 - Commitments And Contingencies (Q2)
Note 13 - Commitments And Contingencies (Q2) (1) (Details)
Note 13 - Commitments And Contingencies (Q2) (2) (Details)
Note 13 - Commitments And Contingencies (Q2) (3) (Details)
Note 13 - Commitments And Contingencies (Q2) (Details)
Note 13 - Commitments And Contingencies (Q2) (Tables)
Note 14 - Revenue (Narrative) (Q2) (Details)
Note 14 - Revenue (Q2)
Note 14 - Revenue (Q2) (Details)
Note 14 - Revenue (Q2) (Tables)
Note 15 - Related Party Transactions (Narrative) (Q2) (Details)
Note 15 - Related Party Transactions (Q2)
Note 16 - Stock-Based Compensation (Narrative) (Q2) (Details)
Note 16 - Stock-Based Compensation (Q2)
Note 17 - Earnings (Loss) Per Share (Q2)
Note 17 - Earnings (Loss) Per Share (Q2) (Details)
Note 17 - Earnings (Loss) Per Share (Q2) (Tables)
Note 18 - Subsequent Events (Narrative) (Q2) (Details)
Note 18 - Subsequent Events (Q2)
Note 2 - Going Concern (Narrative) (Q2) (Details)
Note 2 - Going Concern (Q2)
Note 3 - Summary Of Significant Accounting Policies (Narrative) (Q2) (Details)
Note 3 - Summary Of Significant Accounting Policies (Q2)
Note 3 - Summary Of Significant Accounting Policies (Q2) (Policies)
Note 4 - Accrued Expenses (Q2)
Note 4 - Accrued Expenses (Q2) (Details)
Note 4 - Accrued Expenses (Q2) (Tables)
Note 5 - Contract Liabilities (Narrative) (Q2) (Details)
Note 5 - Contract Liabilities (Q2)
Note 5 - Contract Liabilities (Q2) (Details)
Note 5 - Contract Liabilities (Q2) (Tables)
Note 6 - Short Term Notes Payable (Narrative) (Q2) (Details)
Note 6 - Short Term Notes Payable (Q2)
Note 7 - Convertible Promissory Note (Narrative) (Q2) (Details)
Note 7 - Convertible Promissory Note (Q2)
Note 8 - Sba Loans (Narrative) (Q2) (Details)
Note 8 - Sba Loans (Q2)
Note 9 - Notes Payable, Related Parties (Narrative) (Q2) (Details)
Note 9 - Notes Payable, Related Parties (Q2)
Notes Payable, Related Parties (Fy)
Notes Payable, Related Parties (Narrative) (Fy) (Details)
Preferred Stock (Fy)
Preferred Stock (Narrative) (Fy) (Details)
Property And Equipment (Fy)
Property And Equipment (Fy) (Details)
Property And Equipment (Fy) (Tables)
Property And Equipment (Narrative) (Fy) (Details)
Related Party Transactions (Fy)
Related Party Transactions (Narrative) (Fy) (Details)
Revenue (Fy)
Revenue (Fy) (Details)
Revenue (Fy) (Tables)
Revenue (Narrative) (Fy) (Details)
Segment And Geographic Information (Fy)
Short Term Notes Payable (Fy)
Short Term Notes Payable (Narrative) (Fy) (Details)
Stock-Based Compensation (Fy)
Stock-Based Compensation (Fy) (1) (Details)
Stock-Based Compensation (Fy) (2) (Details)
Stock-Based Compensation (Fy) (Details)
Stock-Based Compensation (Fy) (Tables)
Stock-Based Compensation (Narrative) (Fy) (Details)
Subsequent Events (Fy)
Subsequent Events (Fy) (Details)
Summary Of Significant Accounting Policies (Fy)
Summary Of Significant Accounting Policies (Fy) (Details)
Summary Of Significant Accounting Policies (Fy) (Policies)
Summary Of Significant Accounting Policies (Fy) (Tables)
Summary Of Significant Accounting Policies (Narrative) (Fy) (Details)
Warrants (Fy)
Warrants (Fy) (1) (Details)
Warrants (Fy) (Details)
Warrants (Fy) (Tables)
Warrants (Narrative) (Fy) (Details)

Material Contracts, Statements, Certifications & more

Sanuwave Health, Inc. provided additional information to their SEC Filing as exhibits

Ticker: SNWV
CIK: 1417663
Form Type: S-1 Registration of Securities
Accession Number: 0001140361-20-022459
Submitted to the SEC: Mon Oct 05 2020 5:15:21 PM EST
Accepted by the SEC: Mon Oct 05 2020
Period: Monday, October 5, 2020
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/snwv/0001140361-20-022459.htm